The U.S. Food and Drug Administration (FDA) said Thursday that it has restricted imports from an Indian health care company amid a multistate bacterial outbreak linked to recalled eye drops.
At least one person has died, five are permanently blind, and at least 55 cases have been identified as of Jan. 31 in the 12-state outbreak involving a rare and “extensively drug-resistant” strain of Pseudomonas aeruginosa bacteria, according to federal agencies.
